{
    "nct_id": "NCT03573804",
    "official_title": "The Prone to Supine Breast MRI Trial",
    "inclusion_criteria": "* Age > 18 years.\n* Female gender.\n* Histologic diagnosis of invasive breast cancer or ductal carcinoma in situ\n* Tumor size at least 1 cm in diameter as visualized on mammogram or US.\n* A diagnostic breast MRI is considered to be clinically indicated.\n* Ability to voluntarily provide informed consent to participate prior to any study-related assessments/procedures being conducted.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Absolute contraindication to MRI, including presence of implanted electrical device (pacemaker or neurostimulator), aneurysm clip, or metallic foreign body in or near eyes.\n* Severe claustrophobia.\n* Contraindication to use of gadolinium-based intravenous contrast, including life- threatening allergy or compromised renal function (eGFR < 30 ml/min/1.73m2).\n* History of median sternotomy.\n* Pregnancy. Patient attestation that they are not pregnant will be acceptable.\n* Patients who have received neoadjuvant chemotherapy.",
    "miscellaneous_criteria": ""
}